ArticleFrontiers in endocrinology2024

Who can benefit from postmastectomy radiotherapy among HR+/HER2- T1-2 N1M0 breast cancer patients? An explainable machine learning mortality prediction based approach.

Long Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.